Drugs / Jiedu Tongluo granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03147053 | Apr → Jul 2017 | — | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jiedu Tongluo granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03147053 ↗ |
| Known as | JDTLG | “The treatment group will receive Jiedu Tongluo granules (JDTLG) with conventional treatment, and the placebo group will receive placebo with conventional treatment for 8 weeks.” PMID 29747670 ↗ May 2018 |
| Modality | Traditional medicine (herbal / TCM) | “Traditional Chinese medicine has been used to treat PSD with few side effects.” PMID 29747670 ↗ May 2018 |